Galderma R&D Adopts Agilent Technologies’ Electronic Lab Notebook
News Feb 09, 2010
Agilent Technologies, Inc. and Galderma R&D announced that Galderma has adopted the Agilent Electronic Lab Notebook (ELN) to automate scientific data management at its main R&D centre, the largest facility of its type devoted to dermatological research and development.
“We involved our end users in demonstration sessions based on our workflow for chemistry,” said Catherine Parigot, project leader, Information Management Department, Galderma R&D in Sophia-Antipolis. After comparison with the leading solutions on the market, the user choice of Agilent ELN was unanimous. This was based largely on the ergonomics of the interface and the intuitive navigation through the different functions. Agilent was also able to demonstrate integration with existing information systems, such as our SDMS and our molecular registration system.”
“Electronic lab notebook systems is a very competitive category and we are extremely pleased that the Galderma team recognized the efficiencies, ease-of-use and high-level of support of the Agilent ELN,” said Debra Toburen, Agilent senior product manager, Informatics. “This is just the latest example of the rapid growth of the Agilent ELN product line.”
The Agilent ELN’s open architecture is designed to simplify and accelerate the R&D process by streamlining data capture, speeding data search and retrieval, and eliminating redundant data entry. The system facilitates cross-team collaboration and easily integrates with existing processes and procedures. Agilent ELN contains safeguards for intellectual property and maintains record traceability.
“The use of the intrinsic Analytical Request Module (ARM) to manage our analytical workflow will enable us to replace our existing LIMS application,” Parigot added. “The scope of this initial project will therefore provide an ELN to our chemists and our analysts and trace all the interactions between these two groups.”
Existing 20-year-old Multiple Sclerosis Drug Effective Against Multi-resistant BacteriaNews
A widely-used and twenty-year-old medicine used to treat multiple sclerosis can also beat a type of multi-resistant bacteria for which there are currently only a few effective drugs.READ MORE
Revolutionary Imaging Technique Uses CRISPR to Map DNA MutationsNews
The new high-speed AFM method can map DNA to a resolution of tens of base pairs while creating images up to a million base pairs in size. And it does it using a fraction of the amount of specimen required for DNA sequencing.READ MORE
AIDS Vaccine Design: New Data Offers Important InsightNews
New data published in Immunity further illuminate how some human beings generate powerful, HIV-blocking antibodies. The results offer important insight into a potential AIDS vaccine design.READ MORE